Overview
This document serves as a formal correction to the article "Impaired oxygen-sensitive regulation of mitochondrial biogenesis within the von Hippel–Lindau syndrome," originally published in Nature Metabolism in June 2022. The correction addresses a nomenclature error in the labeling of protein isoforms within the study's figures, specifically regarding Hypoxia-Inducible Factor (HIF) proteins.
Context of the Original Research
The original study investigates the molecular pathology of von Hippel–Lindau (VHL) syndrome, a hereditary condition caused by mutations in the VHL gene. Under normal physiological conditions, the VHL protein acts as a critical oxygen sensor. It identifies and targets Hypoxia-Inducible Factors (HIFs) for degradation when oxygen levels are sufficient.
In patients with VHL syndrome, this degradation pathway is compromised. This leads to the constitutive stabilization of HIF proteins, creating a "pseudohypoxic" state. The research specifically explores how this disruption negatively impacts mitochondrial biogenesis—the cellular process of generating new mitochondria—thereby altering the metabolic profile of affected cells.
Description of the Correction
The correction identifies a technical labeling error in Figure 4, panels i and j. In the original version of the paper, the right-hand lane labels incorrectly identified a specific protein as "HIF1α-P-OH."
Upon review, it was determined that these labels should have identified the protein as "HIF2α-P-OH." This correction ensures that the visual data accurately reflects the experimental findings and the specific protein isoforms being analyzed.
Scientific Significance of the Correction
Distinguishing between HIF1α and HIF2α is fundamental to the study of hypoxia and tumor biology. While these isoforms are structurally related, they often regulate distinct sets of target genes and play different roles in metabolic reprogramming and tumor progression.
The Role of Prolyl-Hydroxylation (P-OH)
The "P-OH" designation refers to the prolyl-hydroxylated form of the HIF protein. Hydroxylation is the specific chemical modification that serves as a signal for the VHL protein to initiate degradation. Correctly identifying which isoform is being hydroxylated in the experimental results is essential for:
- Accurate Signaling Models: Mapping the precise pathway from oxygen sensing to mitochondrial regulation.
- Reproducibility: Allowing other researchers to accurately replicate the biochemical assays and Western blot results.
- Data Integrity: Ensuring the visual evidence in the figures aligns with the authors' conclusions regarding the role of HIF2α in this metabolic context.
Conclusion
The authors have updated both the HTML and PDF versions of the original article to reflect these changes. While the underlying scientific conclusions regarding the impairment of mitochondrial biogenesis in VHL syndrome remain supported, this correction provides the necessary clarity regarding the specific HIF isoforms involved in the regulatory signaling pathway.
Summary updated